News coverage for Seligson et al. Nature 2005 in which we showed that lower global levels of histone modifications in prostate cancer tissues are prognostic of poor clinical outcome. Since this publication, the utility of histone modifications in cancer prognosis has been extended to additional histone modifications and multiple cancer types, regardless of tissue of origin.